Collagenase Santyl: Phase IV started

DFB's HealthPoint Ltd. subsidiary began a double-blind, placebo-controlled, U.S. Phase IV trial to evaluate topical Collagenase Santyl vs. white petrolatum for 4 weeks in 100 patients. Healthpoint pur...